Skip to content

Clinical trials

Phase 4 Diabetic Nephropathies trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Phase: Phase 4 Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20092
20171
20191
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Not yet recruiting2
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Michigan2
Boehringer Ingelheim1
Columbia University1
Keryx Biopharmaceuticals1
Southeast Renal Research Institute1
Stanford University1
University of Colorado, Denver1
VA Office of Research and Development1
Washington D.C. Veterans Affairs Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies10
Diabetes Mellitus2
Diabetes Mellitus, Type 22
Diabetes Mellitus, Type 11
Diabetic Neuropathies1
Glomerulonephritis, IGA1
Glomerulonephritis, Membranous1
Glomerulosclerosis, Focal Segmental1
Hypertension1
Nephrotic Syndrome1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.